- Home
- UP vs CSTL Comparison
UP vs CSTL Comparison
Compare UP & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UP
- CSTL
- Stock Information
- Founded
- UP 2013
- CSTL 2007
- Country
- UP United States
- CSTL United States
- Employees
- UP N/A
- CSTL N/A
- Industry
- UP Aerospace
- CSTL Medical Specialities
- Sector
- UP Consumer Discretionary
- CSTL Health Care
- Exchange
- UP Nasdaq
- CSTL Nasdaq
- Market Cap
- UP 597.8M
- CSTL 568.2M
- IPO Year
- UP N/A
- CSTL 2019
- Fundamental
- Price
- UP $1.43
- CSTL $16.79
- Analyst Decision
- UP
- CSTL Strong Buy
- Analyst Count
- UP 0
- CSTL 6
- Target Price
- UP N/A
- CSTL $38.33
- AVG Volume (30 Days)
- UP 714.2K
- CSTL 540.5K
- Earning Date
- UP 05-01-2025
- CSTL 05-05-2025
- Dividend Yield
- UP N/A
- CSTL N/A
- EPS Growth
- UP N/A
- CSTL N/A
- EPS
- UP N/A
- CSTL N/A
- Revenue
- UP $772,533,000.00
- CSTL $347,083,000.00
- Revenue This Year
- UP $174.46
- CSTL N/A
- Revenue Next Year
- UP N/A
- CSTL $3.14
- P/E Ratio
- UP N/A
- CSTL N/A
- Revenue Growth
- UP N/A
- CSTL 38.43
- 52 Week Low
- UP $0.74
- CSTL $15.70
- 52 Week High
- UP $4.59
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- UP 69.44
- CSTL 31.31
- Support Level
- UP $1.04
- CSTL $15.70
- Resistance Level
- UP $1.52
- CSTL $17.70
- Average True Range (ATR)
- UP 0.13
- CSTL 1.06
- MACD
- UP 0.07
- CSTL -0.36
- Stochastic Oscillator
- UP 88.31
- CSTL 15.25
About UP Wheels Up Experience Inc.
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.